[A] weak yen and rising interest rates have continued even further, with the primary cause being the increase in crude oil prices due to U.S. attacks on Iran.
If the [U.S.-Saudi] nuclear deal hits a deadlock, Riyadh may pivot to alternative suppliers — a shift that would significantly erode American strategic leverage in the Middle East.
Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.